Clinical Trials Browser

Interventional × Carcinoma, Small Cell × Gemcitabine × Clear all

NCT02489903 2025-03-17

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Phase 2 Completed

139 enrolled 14 charts

EndocrineGynecologicNETThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT00129974 2017-06-16

Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer

Phase 2 Terminated

1 enrolled 3 charts

Lung Neoplasms, Carcinoma, Small Cell

NCT00906061 2009-05-21

Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell